539 related articles for article (PubMed ID: 32841736)
1. TMAO: how gut microbiota contributes to heart failure.
Zhang Y; Wang Y; Ke B; Du J
Transl Res; 2021 Feb; 228():109-125. PubMed ID: 32841736
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota Composition and Cardiovascular Disease: A Potential New Therapeutic Target?
Belli M; Barone L; Longo S; Prandi FR; Lecis D; Mollace R; Margonato D; Muscoli S; Sergi D; Federici M; Barillà F
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569352
[TBL] [Abstract][Full Text] [Related]
3. Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis.
Nagatomo Y; Tang WH
J Card Fail; 2015 Dec; 21(12):973-80. PubMed ID: 26435097
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Microbiome in Heart Failure.
Kitai T; Kirsop J; Tang WH
Curr Heart Fail Rep; 2016 Apr; 13(2):103-9. PubMed ID: 26886380
[TBL] [Abstract][Full Text] [Related]
5. Pathobiological Relationship of Excessive Dietary Intake of Choline/L-Carnitine: A TMAO Precursor-Associated Aggravation in Heart Failure in Sarcopenic Patients.
Bin-Jumah MN; Gilani SJ; Hosawi S; Al-Abbasi FA; Zeyadi M; Imam SS; Alshehri S; Ghoneim MM; Nadeem MS; Kazmi I
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684454
[TBL] [Abstract][Full Text] [Related]
6. The heart and gut relationship: a systematic review of the evaluation of the microbiome and trimethylamine-N-oxide (TMAO) in heart failure.
Anderson KM; Ferranti EP; Alagha EC; Mykityshyn E; French CE; Reilly CM
Heart Fail Rev; 2022 Nov; 27(6):2223-2249. PubMed ID: 35726110
[TBL] [Abstract][Full Text] [Related]
7. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
8. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.
Trøseid M; Andersen GØ; Broch K; Hov JR
EBioMedicine; 2020 Feb; 52():102649. PubMed ID: 32062353
[TBL] [Abstract][Full Text] [Related]
9. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Heart Fail Clin; 2020 Jan; 16(1):23-31. PubMed ID: 31735312
[TBL] [Abstract][Full Text] [Related]
10. Trimethylamine N-oxide in cardiovascular disease.
Konieczny RA; Kuliczkowski W
Adv Clin Exp Med; 2022 Aug; 31(8):913-925. PubMed ID: 35438848
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?
Chaikijurajai T; Tang WHW
Curr Heart Fail Rep; 2021 Apr; 18(2):23-32. PubMed ID: 33559845
[TBL] [Abstract][Full Text] [Related]
12. Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.
Emoto T; Hayashi T; Tabata T; Yamashita T; Watanabe H; Takahashi T; Gotoh Y; Kami K; Yoshida N; Saito Y; Tanaka H; Matsumoto K; Hayashi T; Yamada T; Hirata KI
Int J Cardiol; 2021 Sep; 338():138-142. PubMed ID: 34102245
[TBL] [Abstract][Full Text] [Related]
13. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Cardiol Clin; 2022 May; 40(2):161-169. PubMed ID: 35465890
[TBL] [Abstract][Full Text] [Related]
14. Heart Failure Disturbs Gut-Blood Barrier and Increases Plasma Trimethylamine, a Toxic Bacterial Metabolite.
Drapala A; Szudzik M; Chabowski D; Mogilnicka I; Jaworska K; Kraszewska K; Samborowska E; Ufnal M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32859047
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol Attenuates Trimethylamine-N-Oxide (TMAO)-Induced Atherosclerosis by Regulating TMAO Synthesis and Bile Acid Metabolism via Remodeling of the Gut Microbiota.
Chen ML; Yi L; Zhang Y; Zhou X; Ran L; Yang J; Zhu JD; Zhang QY; Mi MT
mBio; 2016 Apr; 7(2):e02210-15. PubMed ID: 27048804
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide.
Zhu Y; Li Q; Jiang H
APMIS; 2020 May; 128(5):353-366. PubMed ID: 32108960
[TBL] [Abstract][Full Text] [Related]
17. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
Romano KA; Vivas EI; Amador-Noguez D; Rey FE
mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
[TBL] [Abstract][Full Text] [Related]
18. Targeting the human microbiome and its metabolite TMAO in cardiovascular prevention and therapy.
Dannenberg L; Zikeli D; Benkhoff M; Ahlbrecht S; Kelm M; Levkau B; Polzin A
Pharmacol Ther; 2020 Sep; 213():107584. PubMed ID: 32446759
[TBL] [Abstract][Full Text] [Related]
19. Dietary metabolism, the gut microbiome, and heart failure.
Tang WHW; Li DY; Hazen SL
Nat Rev Cardiol; 2019 Mar; 16(3):137-154. PubMed ID: 30410105
[TBL] [Abstract][Full Text] [Related]
20. Microbiome, trimethylamine N-oxide, and cardiometabolic disease.
Tang WH; Hazen SL
Transl Res; 2017 Jan; 179():108-115. PubMed ID: 27490453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
